Sunshine Biopharma, Inc.: Revision history

20 August 2022

• curprev 19:1019:10, 20 August 2022 95.149.241.133 talk 1,019 bytes +11 No edit summary undo

14 August 2022

• curprev 05:2705:27, 14 August 2022 109.180.50.163 talk 1,008 bytes +15 No edit summary undo

31 July 2022

• curprev 02:4402:44, 31 July 2022 >Chris 993 bytes +993 Created page with "Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung ca..."